Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGFBR1 | P36897 | 2/20 | 0.52 |
| ▸ | TGFBR2 | P37173 | 1/20 | 0.52 |
| ▸ | TRPA1 | O75762 | 10/20 | 0.51 |
| ▸ | GSK3B | P49841 | 4/20 | 0.50 |
| ▸ | CLK1 | P49759 | 2/20 | 0.50 |
| ▸ | NOS1 | P29475 | 1/20 | 0.50 |
| ▸ | DYRK3 | O43781 | 1/20 | 0.50 |
| ▸ | CLK2 | P49760 | 1/20 | 0.50 |
| ▸ | CLK3 | P49761 | 1/20 | 0.50 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.50 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.50 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.50 |
| ▸ | DYRK2 | Q92630 | 1/20 | 0.50 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.50 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.50 |
| ▸ | ROCK2 | O75116 | 3/20 | 0.49 |
| ▸ | PIM1 | P11309 | 3/20 | 0.49 |
| ▸ | AURKB | Q96GD4 | 3/20 | 0.49 |
| ▸ | JAK2 | O60674 | 1/20 | 0.47 |
| ▸ | PAK4 | O96013 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24427504 | 0.82 | TRPA1 (0.51) | TGFBR1TGFBR2TRPA1GSK3BCLK1 | |
| SCHEMBL18041627 | 0.79 | TGFBR1 (0.83) | TGFBR1TGFBR2TRPA1GSK3BCLK1 | |
| SCHEMBL18041496 | 0.78 | TGFBR1 (0.54) | TGFBR1TGFBR2TRPA1GSK3BCLK1 | |
| SCHEMBL18041464 | 0.77 | TGFBR1 (0.53) | TGFBR1TGFBR2TRPA1GSK3BCLK1 | |
| SCHEMBL18041734 | 0.76 | TGFBR1 (0.58) | TGFBR1TGFBR2TRPA1GSK3BCLK1 | |
| SCHEMBL18041489 | 0.76 | TGFBR1 (0.55) | TGFBR1TGFBR2TRPA1GSK3BCLK1 | |
| SCHEMBL18041614 | 0.75 | TRPA1 (0.50) | TGFBR1TGFBR2TRPA1GSK3BCLK1 | |
| SCHEMBL29676970 | 0.75 | TGFBR1 (0.62) | TGFBR1TGFBR2TRPA1GSK3BCLK1 | |
| SCHEMBL29677021 | 0.75 | TRPA1 (0.50) | TGFBR1TGFBR2TRPA1GSK3BCLK1 | |
| SCHEMBL18041637 | 0.75 | TGFBR1 (0.62) | TGFBR1TGFBR2TRPA1GSK3BCLK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11518766-B2 | Tricyclic compound, preparation method therefor and use thereof | SHANGHAI JEMINCARE PHARMACEUTICALS CO., LTD. (CN) | 2022-12-06 | — | — | US | disclosed |
| EP-3998263-A1 | TRICYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF | Shanghai Jemincare Pharmaceuticals Co., Ltd. (CN) | 2022-05-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11518766-B2 | Tricyclic compound, preparation method therefor and use thereof | TFPI, TFPI2, F11 | TGFBR1 2534/4885TGFBR2 2766/4885TRPA1 1687/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.